KLOW Blend
Also known as GHK-Cu + BPC-157 + TB-500 + KPV
Aesthetic/repair/anti-inflammatory blend
Extends the GLOW profile with KPV, an alpha-MSH fragment studied for its anti-inflammatory action in gut and skin tissue.
How it works
The KLOW blend extends the GLOW combination by adding KPV, a tripeptide fragment derived from alpha-melanocyte-stimulating hormone. KPV retains anti-inflammatory activity from the parent molecule without the pigmentation effects associated with full melanocortin receptor agonists.
KPV's proposed mechanism centers on inhibiting NF-kB signaling, a central pathway driving inflammatory gene expression. Adding this to the GHK-Cu, BPC-157, and TB-500 combination introduces an inflammation-resolution component alongside the dermal remodeling and tissue repair pathways already present in GLOW.
Animal colitis models studying KPV report reduced colonic inflammation, which researchers extrapolate as supportive evidence for its inclusion in a broader repair and recovery blend, though the four-peptide combination itself has not been studied as a single unit in published trials.
What research has shown
KPV research shows reduced colonic inflammation in animal colitis models; other components as described individually.
Reported ranges in the literature
Low end
≈0.5 mg total daily
Optimal
≈1 mg total daily
High end
≈2 mg total daily
Frequency reported in the literature: Daily, 4 to 8 week blocks
Frequently asked questions
What is the KLOW blend?
KLOW combines GHK-Cu, BPC-157, TB-500, and KPV, extending the GLOW blend with an added anti-inflammatory component.
How does KLOW differ from GLOW?
KLOW contains the same three base peptides as GLOW plus KPV, an alpha-MSH fragment studied for NF-kB inhibition and anti-inflammatory signaling in gut and skin research models.
What does the research show?
KPV research reports reduced colonic inflammation in animal colitis models, while the other three components are supported by their individual repair and dermal literature.
How is KLOW stored?
It should be kept refrigerated or frozen prior to reconstitution and refrigerated with a defined use window afterward, consistent with other lyophilized peptide blends.
How long are research blocks typically?
Published protocols for the component peptides suggest daily dosing over 4 to 8 week blocks.
Related compounds
Further reading
Research use only
All content on this page is general reference information for laboratory research contexts. It is not medical advice, is not intended to direct human use, and does not replace guidance from a licensed healthcare professional. Not for human consumption. Must be 18+.